Search for: "State v. Hendrix" Results 41 - 60 of 172
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 May 2022, 10:59 am by Amy Howe
The court also sought the Biden administration’s views in United States ex rel. [read post]
31 Aug 2020, 11:57 am by Brian Shiffrin
Brown, 21 A.D.2d 738, 249 N.Y.S.2d 922; State v. [read post]
15 Mar 2019, 9:00 am by Staff
Subsequent to the FDA approval of Epidiolox, The Drug Enforcement Administration (DEA) issued a Final Order placing “FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 percent tetrahydrocannabinols” [such as Epidiolox] in Schedule V of the Controlled Substances Act,”  “Schedule V drugs are considered to have the lowest potential for abuse compared to other scheduled drugs and a low potential for psychological or physical… [read post]
31 Jan 2018, 12:58 am by Jani Ihalainen
This has been considered by the UK Court of Appeal to potentially apply to performances by deceased artists in the case of Experience Hendrix LLC v Purple Haze Records Ltd (which dealt with performances by the late Jimi Hendrix). [read post]
29 Dec 2017, 7:34 am by Ben
In the UK in FAPL v BT [2017] Mr Justice Arnold concluded that the High Court has the jurisdiction to make an order against an access provider that would require the ISP to block access not to a website but rather streaming servers giving unauthorised access to copyright content - 'live' blocking. [read post]
10 Aug 2017, 3:41 pm
| "Big Box" not found generic or lacking distinctive character, but still .... | Changes to the Singapore copyright system: an update on the recent public consultations | he diplomatic crisis of Qatar and Gulf Cooperation Council's IP | Bundesgerichtshof's landmark ruling to hook extra-territorial patent infringement in Germany | BREAKING: Eli Lilly success as UK Supreme Court finds Actavis products directly and indirectly infringe pemetrexed patent | Monday Miscellany | Sunday… [read post]
15 Jul 2017, 5:11 am
The summary stated that the Supreme Court allows Eli Lilly's appeal and holds that Actavis' products directly infringe Eli Lilly's patent in the United Kingdom, France, Italy and Spain. [read post]